Literature DB >> 15141308

Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli.

D Deckers1, B Masschalck, A Aertsen, L Callewaert, C G M Van Tiggelen, M Atanassova, C W Michiels.   

Abstract

The product of the Escherichia coli ORFan gene ykfE was recently shown to be a strong inhibitor of C-type lysozyme in vitro. The gene was correspondingly renamed ivy (inhibitor of vertebrate lysozyme), but its biological function in E. coli remains unknown. In this work, we investigated the role of Ivy in the resistance of E. coli to the bactericidal effect of lysozyme in the presence of outer-membrane-permeabilizing treatments. Both in the presence of lactoferrin (3.0 mg/ml) and under high hydrostatic pressure (250 MPa), the lysozyme resistance of E. coli MG1655 was decreased by knock-out of Ivy, and increased by overexpression of Ivy. However, knock-out of Ivy did not increase the lysozyme sensitivity of an E. coli MG1655 mutant previously described to be resistant to lysozyme under high pressure. These results indicate that Ivy is one of several factors that affect lysozyme resistance in E. coli, and suggest a possible function for Ivy as a host interaction factor in commensal and pathogenic E. coli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141308     DOI: 10.1007/s00018-004-4066-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  25 in total

Review 1.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

2.  The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase.

Authors:  Chelsea A Clarke; Edie M Scheurwater; Anthony J Clarke
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

3.  Detection of a lysozyme inhibitor in Proteus mirabilis by a new reverse zymogram method.

Authors:  Lien Callewaert; Lise Vanderkelen; Daphne Deckers; Abram Aertsen; Johan Robben; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

4.  The Rcs two-component system regulates expression of lysozyme inhibitors and is induced by exposure to lysozyme.

Authors:  Lien Callewaert; Kristof G A Vanoirbeek; Ine Lurquin; Chris W Michiels; Abram Aertsen
Journal:  J Bacteriol       Date:  2009-01-09       Impact factor: 3.490

Review 5.  Invertebrate lysozymes: diversity and distribution, molecular mechanism and in vivo function.

Authors:  Joris M Van Herreweghe; Chris W Michiels
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

6.  Structural evidence for lack of inhibition of fish goose-type lysozymes by a bacterial inhibitor of lysozyme.

Authors:  Peter Kyomuhendo; Inge W Nilsen; Bjørn Olav Brandsdal; Arne O Smalås
Journal:  J Mol Model       Date:  2008-05-20       Impact factor: 1.810

7.  A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.

Authors:  Stephanie N Joslin; Christine Pybus; Maria Labandeira-Rey; Amanda S Evans; Ahmed S Attia; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

8.  Edwardsiella tarda MliC, a lysozyme inhibitor that participates in pathogenesis in a manner that parallels Ivy.

Authors:  Mo-Fei Li; Chong Wang; Li Sun
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

9.  Isolation of a broad spectrum antimicrobial producing thermophilic Bacillus and characterization of its antimicrobial protein.

Authors:  Purusottam Ojha; Narayani Prasad Kar; Shreenath Nayak; Ashok Kumar Patra; Khirod Kumar Sahoo
Journal:  Arch Microbiol       Date:  2021-02-11       Impact factor: 2.552

10.  The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalis.

Authors:  André Le Jeune; Riccardo Torelli; Maurizio Sanguinetti; Jean-Christophe Giard; Axel Hartke; Yanick Auffray; Abdellah Benachour
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.